glp-1 and psoriasis Drug Makes Its Case for Treating Plaque The Dermatologist | π₯ GLP-1s
Description
[00:28:40] Emily Field: Because if we just want this whole episode talking about why muscle matters, why training matters, and why preserving strength matters, then we also have to acknowledge this
Although the study reports that the majority of these were mild/moderate (and only 4.5% discontinued treatment due to GI side effects) you do wonder if this had an impact on the weight loss
These drugs can reduce obesity-related medical diseases, leading to fewer interventions
The field is moving quickly, and the clinical frameworks around these medications are still maturing
